Healthcare compliance advisory for hospitals, clinics, pharma and diagnostics brands in India
Most healthcare brands in India are exposed to three or more regulatory regimes at once — NMC, ASCI, DPDP, UCPMP, AYUSH, NABH — but manage each one separately, if at all, usually only after something has already gone wrong. ICG runs a single advisory that audits every regime that applies to your entity, remediates what's flagged, trains the team that produces new content, and stays on as a retainer so the next campaign, form or marketing leaflet clears the bar before it goes live.
TL;DR
- Six regulatory regimes touch healthcare brands in India — NMC, ASCI, DPDP, UCPMP, AYUSH and NABH — and most brands are exposed to at least three of them simultaneously without a single team owning any of it.
- ICG runs one advisory across every regime relevant to your entity type, rather than a separate lawyer or consultant for each, so overlapping requirements are checked together instead of in silos that miss each other's blind spots.
- The engagement covers audit, remediation, team training and an ongoing retainer — a one-time fix doesn't survive the next campaign written under deadline pressure.
- Rohit Gupta leads commercial strategy across all six regimes; Adrito Basu, ICG's NABH Lead with 15+ years in healthcare accreditation, leads the NABH-specific workstream.
- Retainers from Rs 20,000/month, custom-scoped per engagement — scope is set by which regimes apply and how many facilities, ad accounts or product lines need coverage.
What the regulator actually requires in 2026
Healthcare in India isn't regulated by one body with one rulebook — it's regulated by at least six overlapping regimes, each with a different scope, a different enforcement mechanism, and a different set of assets it actually reaches into. A single hospital marketing campaign can trip more than one at once, and the brands that get caught out are almost never the ones ignoring compliance outright — they're the ones managing one regime carefully while never realising a second one applied to the same piece of content.
The National Medical Commission (NMC), through its Registered Medical Practitioner regulations, governs how an individual doctor can advertise for patients — no soliciting, no advertising personal achievements as a promotional device, no endorsement-style claims attached to a named practitioner. The Advertising Standards Council of India (ASCI), under Chapter III of its Code, governs the advertising itself for health, wellness and aesthetic services — before/after imagery, superiority claims, testimonials — and applies regardless of which practitioner or entity is behind the ad. The Digital Personal Data Protection Act (DPDP) 2023 governs how patient data is collected, stored, consented to and shared — every intake form, appointment booking flow and CRM integration a hospital or clinic runs falls under it, often without the marketing team realising data-protection rules apply to what looks like a lead-generation form. The Uniform Code for Pharmaceuticals Marketing Practices (UCPMP) governs how pharma companies market to physicians specifically — gifts, hospitality, sample distribution and promotional material to prescribers, an entirely separate exposure surface from consumer-facing advertising. AYUSH advertising rules add a further layer for Ayurveda, Yoga, Unani, Siddha and Homoeopathy brands, restricting disease-cure claims with a stricter substantiation bar than allopathic advertising typically faces. And NABH accreditation standards, while not an advertising regime at all, set the quality-management and documentation bar hospitals and diagnostic centres are increasingly expected to meet — both because payers and corporate clients ask for it, and because accreditation status itself becomes a marketing claim once achieved.
What makes 2026 a different environment from a few years ago is less any single new rule and more the fact that enforcement across all six regimes has become more visible and more interconnected. ASCI's upheld-complaint reports are searchable and increasingly referenced in patient-facing discussions. DPDP enforcement mechanisms have matured since the Act's passage, with data-handling scrutiny now a live conversation for any hospital running digital intake. UCPMP compliance is a recurring theme in pharma industry audits. And NABH accreditation has shifted from a nice-to-have differentiator to something corporate empanelment and insurance-network conversations increasingly assume as a baseline. A brand that's compliant on one regime and blind to the other five isn't meaningfully de-risked — it's exposed on five different fronts it hasn't looked at yet.
The six regimes, at a glance
NMC
Governs how individual registered medical practitioners can advertise, solicit patients and present credentials. Applies to every doctor-facing website bio, social profile and testimonial-led post.
ASCI Chapter III
Governs health and wellness advertising claims across every channel — before/after imagery, superiority language, testimonials, fear-based framing. Complaint-driven and platform-agnostic.
DPDP 2023
Governs consent, storage and handling of patient personal data — every intake form, booking flow and CRM sync a hospital or clinic runs falls under this regime, whether marketing realises it or not.
UCPMP
Governs how pharma companies market to physicians — gifts, hospitality, samples and promotional material to prescribers, a distinct exposure surface from consumer advertising.
AYUSH rules
Governs disease-cure and efficacy claims for Ayurveda, Yoga, Unani, Siddha and Homoeopathy brands, with a stricter substantiation bar than most allopathic advertising faces.
NABH
Sets quality-management and documentation standards for hospitals and diagnostic centres — increasingly a baseline expectation from payers and corporate empanelment, and a marketing claim once achieved.
Common violations we see — anonymised, from real audits
These patterns repeat across nearly every first-pass multi-regime audit ICG runs, regardless of entity type or size. None of the following identifies a real organisation — they're composite patterns drawn from dozens of engagements across hospitals, clinics, pharma companies and diagnostics chains.
- A hospital's website bio page reading like a promotional CV. A senior consultant's profile listed personal accolades, "India's leading" language and a call-to-action to book directly with that named doctor — a pattern that trips NMC's restriction on individual practitioner solicitation even though the marketing team saw it as a standard "meet the doctor" page.
- A patient intake form with no documented consent trail. A multi-city clinic chain's online booking form collected name, phone, condition description and preferred appointment slot with no explicit consent language, no stated data-retention period, and no record of what third-party tools the data flowed into — a DPDP exposure sitting inside what the team thought of purely as a lead-generation form.
- Undated before/after imagery across an aesthetic gallery. The same pattern found repeatedly in ASCI-specific audits — inconsistent lighting, no disclosed timeframe, no documented consent for the specific advertising use.
- MR (medical representative) gifting outside UCPMP limits. A pharma company's field-marketing calendar included physician hospitality and gifting that exceeded UCPMP's permitted thresholds, tracked informally in a spreadsheet with no compliance sign-off step before the event was booked.
- An AYUSH brand's product page claiming a specific disease cure. Marketing copy for an Ayurvedic supplement claimed it "cures" a named chronic condition outright, rather than describing supportive or traditional use — a claim AYUSH rules restrict far more tightly than general wellness marketing typically assumes.
- NABH documentation gaps discovered only at survey time. A hospital preparing for NABH assessment found several required quality-management protocols existed informally but were never documented to the standard's evidentiary bar, a gap that surfaces as a finding during the actual survey rather than months earlier when it was cheaper to fix.
The common thread across every regime isn't malice or even carelessness in most cases — it's that no single person or process at these organisations was responsible for checking new content and workflows against the full regulatory stack before they went live. Each of the six patterns above sits inside a different regime, discovered by a different specialist review, which is precisely the case for running one advisory across all of them rather than assuming each department's silo already has it covered.
ICG's audit + remediation framework
- Scope the applicable regimes. Before anything else, ICG maps which of the six regimes actually apply to your entity type, channel mix and business model — a dental clinic and a pharma manufacturer need entirely different regime coverage, and scoping this correctly is what keeps the engagement priced to actual exposure rather than a blanket package.
- Inventory every relevant surface. Website, ad accounts, social content, patient intake forms and data flows, MR field materials for pharma clients, and existing quality documentation for NABH-track hospitals — all pulled into one register rather than reviewed department by department in isolation.
- Score each item against its specific regime and clause. A doctor bio is checked against NMC, a testimonial against ASCI, a booking form against DPDP, an MR gift log against UCPMP — each flagged with the exact provision it touches, not a generic risk label.
- Prioritise by exposure, not by volume. A patient intake form processing hundreds of records weekly carries more real exposure than a rarely-viewed static page making a similar error, so remediation sequencing follows where the risk actually concentrates.
- Remediate — rewrite copy, redesign forms, document processes. Flagged marketing copy is rewritten to preserve its commercial intent within the rules; intake forms get consent language and retention disclosures added; NABH documentation gaps are closed with the specific evidentiary format the standard requires.
- Train the team and hand back a standing checklist. Marketing, front-desk and MR teams each get a checklist scoped to the regimes that touch their work, so future content and workflows are checked at creation rather than caught after publication or during a survey.
- Re-audit on a cadence. A follow-up pass confirms remediated items stayed compliant and catches anything new since the last review — the step the retainer exists to sustain across all applicable regimes simultaneously.
What clean copy and process look like — worked examples
Remediation isn't about stripping confidence or convenience from a brand's marketing and operations — it's about attaching claims to something substantiable and building consent and documentation into workflows that already exist. Four worked examples, drawn from the pattern types above.
"Dr. [Name], India's most sought-after specialist. Book directly with Dr. [Name] for guaranteed results."
"Dr. [Name], [specialty] consultant with [X] years of clinical experience. Book a consultation through our appointment desk to discuss your specific case."
Booking form collects name, phone and condition with no consent checkbox, no retention statement, no disclosure of third-party data sharing.
Form includes an explicit consent checkbox naming the purpose of collection, a stated retention period, and a disclosure of which third-party systems (CRM, WhatsApp API) the data flows into, with an opt-out path.
"This formulation cures diabetes completely within 90 days."
"A traditional Ayurvedic formulation used to support metabolic wellness as part of a broader lifestyle and dietary plan. Consult a qualified practitioner to discuss fit for your condition."
MR calendar includes an unlogged hospitality event for prescribers with no compliance sign-off and no cap check against UCPMP thresholds.
Every field-marketing event routes through a pre-approval checklist checked against UCPMP thresholds, logged centrally, with sign-off required before the event is booked rather than reviewed after the fact.
Every rewritten or redesigned version keeps the underlying commercial or operational function intact — a doctor still gets a strong bio, a clinic still captures the lead, a supplement still markets its benefit, a field team still builds physician relationships — while removing the specific element each regime restricts. That's the pattern the checklist trains every team to apply on its own, regime by regime, asset by asset.
Ongoing retainer support
A one-time audit fixes what exists today, across every regime it covers. It doesn't catch the doctor bio a new hire writes next quarter, the booking form field added without a consent update, the MR event scheduled during a busy month without the usual sign-off, or the new product claim a marketing team drafts under deadline pressure using language from an old, unreviewed campaign. That's the gap the retainer closes — every new asset and workflow gets a compliance pass scoped to its relevant regime before it launches, not after a complaint, notice or survey finding forces a scramble.
Pre-launch review
New marketing copy, forms, physician-facing materials and product claims are checked against the applicable regime's checklist before they go live, with turnaround built to fit a normal launch timeline.
Monthly re-audit
A standing monthly pass across all covered surfaces catches drift — copy edited after the last review, a new form field added, a documentation gap that's crept back in ahead of a NABH surveillance visit.
Team training
Working sessions with marketing, front-desk, MR and quality teams on the specific patterns their function trips most often across the regimes that apply to them, so the checklist becomes routine rather than a document nobody opens.
Notice and survey response support
If a complaint, notice or NABH survey finding lands on an existing asset or process, ICG helps draft the response and remediation plan the specific regulator or assessor expects, working alongside the brand's legal counsel where one is engaged.
Retainers from Rs 20,000/month, custom-scoped per engagement — the scope depends on which regimes apply, how many facilities, ad accounts and product lines need ongoing coverage, and whether an NABH accreditation workstream is included.
How this integrates with the Search Intelligence Trifecta
Compliance risk doesn't stay inside a single ad account or intake form — it shows up across the same organic content, Google Business Profile activity and video presence ICG's Search Intelligence Trifecta already manages for many clients. Rather than treating compliance as a separate review that catches problems after publication, ICG applies the relevant checklist at the point new content is created inside those existing workflows.
SIE (Search Intelligence Engine) monitors a brand's live search and content footprint continuously, which makes it the surface that catches compliance drift between formal audit cycles — a new blog post with an unsubstantiated claim, a Google Business Profile update with imagery that never went through review, a landing page edited by someone outside the compliance loop. Angryturtle, ICG's Google Business Profile management product, is where a large share of before/after gallery content, review responses and location-page copy actually gets published for hospitals and clinics, so its audit dashboard is one of the two places the checklist is applied directly at the point of publishing. YODA, ICG's YouTube AIO product, carries the same exposure for video testimonials, procedure walkthroughs and doctor-led explainer content, where a spoken claim is just as citable in a complaint as a written one.
How the six-regime checklist runs continuously across SIE, Angryturtle and YODA rather than as a one-time gate.
Illustrative Angryturtle dashboard view — compliance status tracked per location, per regime, alongside the standard GBP audit.
Pricing
The healthcare compliance advisory is priced as an ongoing retainer, not a fixed-fee one-off, because exposure across six regimes is ongoing — a new campaign, form, product claim or MR event goes live every month, each carrying the same category of risk the last audit found. Retainers start from Rs 20,000/month, custom-scoped per engagement, with scope set around which of the six regimes actually apply to your entity, how many facilities, ad accounts or product lines need coverage, and whether an NABH accreditation workstream is included.
Retainers from Rs 20,000/month
Custom-scoped per engagement — no fixed tiers, scoped to your regulatory exposureA single-specialty clinic exposed mainly to NMC and ASCI, running one or two ad accounts and no NABH ambitions, sits at the lower end of that range. A multi-city hospital group pursuing NABH accreditation while also managing DPDP-compliant patient data flows, active advertising, and physician-facing pharma partnerships needs a materially wider scope, priced accordingly. Retainers from Rs 20,000/month, custom-scoped per engagement is the starting conversation, not the ceiling — the exact number is set after ICG maps which regimes apply and sees the account and facility structure in the benchmarking call, never before.
Who this is for
Hospitals and multi-specialty clinics
Especially those advertising actively, running digital intake, or pursuing NABH accreditation across one or more facilities.
Single-specialty clinics and dental chains
Running Google Ads, Meta Ads or before/after-heavy content who've never had a formal NMC or ASCI review.
Pharma companies
With active MR field marketing and consumer-facing OTC advertising, needing UCPMP and ASCI coverage together.
AYUSH and diagnostics brands
Marketing efficacy or disease-related claims that need a substantiation review specific to their category's regulatory bar.
It's less of a fit for an organisation with no active advertising, minimal digital patient data collection, and no accreditation ambitions, where exposure across most of these six regimes is naturally low — ICG will say so directly in a benchmarking call rather than sell a retainer where the risk doesn't justify it. For everyone else operating in Indian healthcare, marketing, or pharma, a multi-regime compliance review isn't optional risk management anymore — it's the baseline a serious organisation runs before a complaint, notice or failed survey forces the conversation.
Get your multi-regime compliance audit started
ICG scopes which of the six regimes apply to your organisation in the first call, then sequences the audit by real exposure. Book a benchmarking call, or message Sr. Leadership directly on WhatsApp.
Frequently asked questions
What is healthcare compliance advisory and why does a hospital or clinic need it?
Healthcare compliance advisory is an ongoing review of everything a healthcare brand publishes and does — advertising, patient data handling, doctor conduct, marketing to physicians, and quality-accreditation readiness — checked against every regulatory regime that applies to it at once. Most Indian healthcare brands are exposed to at least three regimes simultaneously (NMC, ASCI and DPDP at minimum) but manage each in a silo, if at all, which is exactly the gap that produces the violations regulators actually act on.
Which regulators does ICG cover under this advisory?
Six: the National Medical Commission (NMC) for practitioner conduct and advertising, the Advertising Standards Council of India (ASCI) Chapter III for health and wellness advertising claims, the Digital Personal Data Protection Act (DPDP) 2023 for patient data handling, the Uniform Code for Pharmaceuticals Marketing Practices (UCPMP) for pharma-to-physician marketing, AYUSH advertising rules for Ayurveda, Yoga, Unani, Siddha and Homoeopathy brands, and NABH accreditation standards for hospitals and diagnostic centres pursuing or maintaining quality certification.
Do I need all six regimes covered, or only the ones relevant to my business?
Only the ones relevant to you — a single-specialty dental clinic typically needs NMC and ASCI coverage, occasionally DPDP if it runs any digital intake form. A pharma company needs UCPMP and DPDP, and ASCI if it advertises OTC products directly to consumers. A hospital pursuing NABH needs that plus NMC, ASCI and DPDP together. ICG scopes the engagement to the regimes that actually apply to your entity type and channel mix, not all six by default.
How is this different from hiring a lawyer for compliance?
A healthcare compliance lawyer interprets the law and represents a brand if a complaint or notice is filed. ICG's advisory works upstream of that — auditing live marketing assets, patient-data workflows and physician-facing materials against each regime's specific requirements, rewriting what's flagged, training the team that produces new content, and staying on retainer so new material clears the bar before publication. The two functions are complementary — ICG's Adrito Basu-led NABH and healthcare-compliance team works alongside a brand's legal counsel rather than replacing it, and several engagements run both in parallel.
What does the audit and remediation process actually involve?
ICG inventories every live surface relevant to the applicable regimes — website, ad accounts, social content, patient intake forms and data flows, MR (medical representative) materials for pharma clients, and existing quality-management documentation for NABH-track hospitals. Each item is scored against the specific regulatory clause it touches, prioritised by exposure rather than by volume, and flagged copy or process gaps are rewritten or redesigned into a compliant version that still does its commercial job. A reusable checklist and training session hand the framework to the in-house team.
Who leads the compliance advisory team at ICG?
Rohit Gupta, Co-Founder and Business & Growth Lead at ICG, oversees the advisory's commercial scoping and cross-regime strategy. Adrito Basu, ICG's NABH Lead with over 15 years in healthcare quality and accreditation consulting, leads the NABH-specific audit and documentation workstream, and is brought in directly for any engagement with an accreditation component.
Is this advisory for large hospital chains only, or does it work for a single clinic?
Both. The engagement is scoped by entity size and channel complexity, not sold as a fixed package — a single-location clinic with one ad account and no NABH ambitions is a small-scope, lower-cost engagement, while a multi-city hospital group pursuing accreditation across several facilities is a materially larger one. Retainers start from Rs 20,000/month at the smaller end and scale from there.
How does this connect to ICG's other marketing work?
Compliance risk shows up inside the same channels ICG already manages for many clients — Google Business Profile content through Angryturtle, YouTube video through YODA, and the broader organic and paid footprint SIE (Search Intelligence Engine) monitors continuously. Rather than running compliance as a separate silo that reviews content after it's already live, ICG applies the compliance checklist at the point new content is created inside those same workflows, catching drift between formal audit cycles.
What happens if a regulator or platform acts before the audit is complete?
ICG prioritises remediation by exposure, not by the order violations were found, specifically so the highest-traffic and highest-risk assets are fixed first, within days rather than waiting for a full audit to finish end to end. If a complaint, notice or platform takedown does land mid-engagement, ICG helps draft the response and remediation plan the specific regulator expects, working alongside the brand's legal counsel where one is engaged.
How much does the healthcare compliance advisory cost?
Retainers start from Rs 20,000/month and are custom-scoped per engagement, based on how many regulatory regimes apply, how many facilities or ad accounts need coverage, and whether an NABH accreditation workstream is included. A standalone one-time audit can be scoped separately from the ongoing retainer for brands that want a baseline first.
